Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquis Exchange Regulatory News (AQX)

Share Price Information for Aquis Exchange (AQX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 466.00
Bid: 462.00
Ask: 470.00
Change: 0.00 (0.00%)
Spread: 8.00 (1.732%)
Open: 466.00
High: 466.00
Low: 466.00
Prev. Close: 466.00
AQX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of NEX Exchange

5 Jul 2019 07:00

RNS Number : 5782E
Aquis Exchange PLC
05 July 2019
 

5 July 2019

Aquis Exchange PLC

("Aquis", the "Company" or the "Group")

 

Acquisition of NEX Exchange

 

Aquis Exchange PLC (AIM: AQX), the exchange services group that operates pan-European cash equities trading businesses and develops and licenses exchange software to third parties, is pleased to announce that it has agreed to acquire NEX Exchange Limited ("NEX Exchange") from CME Group Inc. (the "Acquisition") for a cash consideration of £1, plus approximately £2.7 million based on NEX Exchange's current working capital levels.

 

NEX Exchange, the UK based stock market for growth enterprises, is one of only four equities-focused Recognised Investment Exchanges (RIEs) in the UK. It works with 51 registered brokers, 7 market makers and 89 companies currently listed on its two markets with a combined market capitalisation of approximately £1.9 billion.

 

This Acquisition is another step in Aquis' ambition to become the leading exchange services group in Europe and provides a unique opportunity to acquire an RIE business with a focus on primary markets in a cost and time effective manner. Underpinned by the Group's proven technology and a track record of transparency and innovation, the Board believes that with Aquis' experience in both building new businesses in the exchange industry and also increasing liquidity, it has the ability to transform NEX Exchange at a time when MiFID II implications and other factors make the industry ripe for innovation. The Board believes that the Acquisition provides a unique opportunity to build a pan-European, technology driven, listing exchange for growth companies.

 

Based on the audited financial accounts for the year ended 31 March 2018, NEX Exchange delivered revenues of £1.51m and a loss before tax of £2.05m. The Company believes that significant cost savings can be delivered in the short term, significantly reducing the loss in the initial period following the Acquisition.

 

Completion of the Acquisition is expected this autumn, subject to FCA approval. The Company will update the market upon receipt of FCA approval and completion.

 

Alasdair Haynes, Chief Executive Officer of Aquis, commented:

"Our stated aim is to become the leading technology-driven exchange services group, and this acquisition is a milestone towards delivering this vision. We have a successful blueprint of proven technology and are confident that we can not only deliver growth but we can also positively address the current issues in small and mid-cap trading. We have the capability, capacity and ambition to drive further shareholder value through this transaction."

 

Ken Vroman, Senior Managing Director, Cash Markets and Optimization Services, CME Group, commented:

"We are pleased to have reached an agreement with Aquis Exchange to acquire NEX Exchange from CME Group. There are natural synergies between the two companies, and we believe Aquis is well positioned to take NEX Exchange to the next level of its growth."

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (MAR).

 

Management will host a conference call for analysts at 8:30am today regarding the Acquisition. Please contact aquis@almapr.co.uk for dial in details.

 

Enquiries:

Aquis Exchange PLC

Tel: +44 (0) 20 3597 6321

Alasdair Haynes, CEO

Jonathan Clelland, CFO and COO

Belinda Keheyan, Head of Marketing

Tel: +44 (0) 7768 078110

Liberum Capital Limited (Nominated Adviser and Broker)

Tel: +44 (0) 20 3100 2000

Clayton Bush

Chris ClarkeEdward Thomas

Kane Collings

Alma PR (Financial PR Adviser)

Tel: +44 (0)20 3405 0209

Rebecca Sanders-Hewett

Caroline Forde

Susie Hudson

aquis@almapr.co.uk

 

About Aquis Exchange

 

Aquis Exchange PLC is an exchange services group, which operates a pan-European cash equities trading business (Aquis Exchange) and develops and licenses exchange software to third parties (Aquis Technologies).

Aquis Exchange PLC (AQX.L) is quoted on the London Stock Exchange's Alternative Investment Market (AIM).

 

Aquis Exchange is authorised and regulated by the UK Financial Conduct Authority and France's Autorité des Marchés Financiers to operate Multilateral Trading Facility businesses in the UK and in EU27 respectively.

Aquis operates a lit order book and does not permit aggressive non-client proprietary trading, which has resulted in lower toxicity and signalling risk on Aquis than other trading venues in Europe. According to independent studies, trades on Aquis are less likely to lead to price movement than on other lit markets. Aquis applies a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each security that they execute. This model can significantly reduce the cost of trading.

Aquis Technologies is the software and technology division of Aquis Exchange PLC. It creates and licenses cutting-edge, cost-effective matching engine and trade surveillance technology for banks, brokers, investment firms and exchanges.

For more information, please go to www.aquis.eu and www.aquis.technology

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQBZLLBKDFLBBQ
Date   Source Headline
22nd Jun 202212:30 pmRNSExercise of Share Options and Total Voting Rights
26th May 20227:00 amRNSChange of registered address
29th Apr 20221:57 pmRNSDirector/PDMR Notification and Issue of Options
26th Apr 20223:05 pmRNSBoard Appointments
26th Apr 20222:59 pmRNSResult of AGM
4th Apr 20228:18 amRNSPublication of Annual Report and Notice of AGM
4th Apr 20227:00 amRNSDirector/PDMR Dealing
1st Apr 20223:53 pmRNSTransfer of UBS MTF Business Activities Completed
30th Mar 20229:35 amRNSExercise of Share Options and Total Voting Rights
29th Mar 20227:10 amRNSFinal Results and Board Appointments
29th Mar 20227:00 amRNSAdmission to Trading on the AQSE Growth Market
16th Mar 20227:00 amRNSTransfer of UBS MTF business activities to Aquis
11th Mar 20227:00 amRNSIntention to Dual List on the AQSE
24th Feb 20227:00 amRNSNotice of Results
8th Feb 20227:00 amRNSAquis Technologies partners with Investre
26th Nov 20219:48 amRNSExercise of Share Options and Total Voting Rights
26th Nov 20217:00 amRNSAppointment of New Chair
25th Nov 20217:00 amRNSDirector/PDMR Notification
23rd Sep 20215:39 pmRNSExercise of Share Options, Director Dealing & TVR
23rd Sep 20217:00 amRNSInterim Results
17th Sep 20217:00 amRNSBoard Appointment
1st Sep 20217:00 amRNSNotice of Results
25th Aug 20217:00 amRNSAppointment of independent NED to AQSE Board
2nd Aug 20217:00 amRNSAquis Exchange achieves record market share
28th Jun 20214:21 pmRNSExercise of Share Options and Director Dealing
27th May 20217:00 amRNSAQSE expands research for its top-tier stocks
18th May 20217:00 amRNSDual quotations with the Frankfurt Stock Exchange
13th May 20217:00 amRNSNew Senior Management Appointments
30th Apr 20217:00 amRNSDirector/PDMR Notification & Issue of Options
27th Apr 202112:41 pmRNSResult of Annual General Meeting
8th Apr 20217:00 amRNSDirector/PDMR Notification
31st Mar 20214:51 pmRNSPublication of ARA and Notice of AGM
31st Mar 20217:00 amRNSFinal Results
26th Mar 20217:00 amRNSNotice of Results
24th Mar 20217:00 amRNSAquis Exchange and ShareSoc Retail Investor Survey
26th Feb 20217:00 amRNSTrading and Operational Update
5th Feb 202112:07 pmRNSAppointment of Joint Broker
4th Feb 20218:03 amRNSAquis Exchange recommences trading in Swiss shares
14th Dec 20207:00 amRNSAQSE rule changes & market segments now in effect
26th Nov 20207:00 amRNSDirector/PDMR Notification
23rd Nov 20207:00 amRNSAQSE launches Market Maker Incentive Scheme
20th Nov 20202:00 pmRNSAquis works with SGX & AWS on cloud deployment
19th Oct 20207:00 amRNSAppointment to the AQSE Board
12th Oct 20207:00 amRNSAppointment of Independent Non-executive Director
9th Sep 20207:00 amRNSInterim Results
27th Aug 20207:00 amRNSNotice of Results
17th Jun 20207:00 amRNSBoard Appointment
16th Jun 20207:00 amRNSHolding(s) in Company
15th Jun 20207:01 amRNSDirector/PDMR Notification
15th Jun 20207:00 amRNSIssue of Options and Director/PDMR Notification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.